Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tooth fillings put to the test in 5-year study

NCT ID NCT06369779

Disease control Sponsor: Ivoclar Vivadent AG Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two new dental filling materials for cavities in back teeth. 65 adults with cavities or old fillings that need replacing will receive the new fillings and be checked for pain, function, and appearance over 5 years. The goal is to see if the materials are safe and work well.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

65 people

The number who actually took part.

Started

May 2024

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Informed Consent signed by the subject * Age: 18-65 years * Indication Class I or II direct restorations in premolars or molars (Replacement of insufficient fillings due to secondary caries, fractures, insufficient marginal adaptation, loss of filling or primary caries) * Cavity width must be at least half of the cusp tip distance * Vital teeth, regular sensitivity * Sufficient language skills * No active periodontits * Preoperative VAS (visual analogue scale) values \< 3 regarding tooth sensitivity and biting Exclusion Criteria: * Sufficient isolation of the cavity not possible * Not completed hygiene phase or poor oral hygiene * Missing antagonist, non-occlusion * Missing tooth adjacent to the tooth to be treated * Restorations replacing more than 1 cusp * Caries profunda or very deep cavity * Patients with a proven allergy to ingredients of the used materials (methacrylates) or local anesthetics (Articain, sulfite) * Patients with severe systemic diseases * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insufficient dental filling or primary caries (class I or II cavities in premolars or molars) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dental caries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Insufficient dental filling or primary caries (class I or II cavities in premolars or molars)

Contacts and locations

Locations

  • Ivoclar Vivadent AG

    Schaan, Liechtenstein, 9494, Liechtenstein